Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Series B funding round

funding round1 mentionslast seen Oct 27, 2026

Preferred equity financing for up to $8,400,000 involving Series B Non-Voting Convertible Preferred Stock and warrants.

Relationships 1

Valion Bio, Inc.funded bySeries B funding round93% confidence1 source

Series B funding round

Relationship

Valion Bio, Inc.funded bySeries B funding round

93% confidence1 supporting mentionsfrom Apr 29, 2025

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 27, 2026Valion Bio, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Securities Purchase Agreement, dated as of April 29, 2025 (as assigned and amended as of December 9, 2025, the "Series B Preferred Purchase Agreement"), with respect to the purchase and sale of (a) up to 8,400 shares of the Company's Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Shares") and (b) warrants ("Series B Warrants") to purchase a number of shares of common stock